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Abstract
Background: Human infections with highly pathogenic avian influenza (HPAI) A (H5N1) viruses have occurred in 15
countries, with high mortality to date. Determining risk factors for morbidity and mortality from HPAI H5N1 can inform
preventive and therapeutic interventions.
Methods: We included all cases of human HPAI H5N1 reported in World Health Organization Global Alert and Response
updates and those identified through a systematic search of multiple databases (PubMed, Scopus, and Google Scholar),
including articles in all languages. We abstracted predefined clinical and demographic predictors and mortality and used
bivariate logistic regression analyses to examine the relationship of each candidate predictor with mortality. We developed
and pruned a decision tree using nonparametric Classification and Regression Tree methods to create risk strata for
mortality.
Findings: We identified 617 human cases of HPAI H5N1 occurring between December 1997 and April 2013. The median age
of subjects was 18 years (interquartile range 6–29 years) and 54% were female. HPAI H5N1 case-fatality proportion was 59%.
The final decision tree for mortality included age, country, per capita government health expenditure, and delay from
symptom onset to hospitalization, with an area under the receiver operator characteristic (ROC) curve of 0.81 (95% CI: 0.76–
0.86).
Interpretation: A model defined by four clinical and demographic predictors successfully estimated the probability of
mortality from HPAI H5N1 illness. These parameters highlight the importance of early diagnosis and treatment and may
enable early, targeted pharmaceutical therapy and supportive care for symptomatic patients with HPAI H5N1 virus infection.
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Introduction
Since 1997, human and poultry outbreaks of highly pathogenic
avian influenza (HPAI) A (H5N1) have had devastating health,
economic, and social impact in 15 countries in Asia, Africa, and
the Middle East [1–6]. During the 2003–2004 HPAI H5N1
outbreak in Southeast Asia, for example, Vietnam culled 45
million birds at a cost of around US $118 million, and the Thai
poultry industry experienced devastating economic losses of US $3
billion [4,7].
Human cases of HPAI H5N1 virus infection with high mortality
continue to be detected sporadically in several countries [8]. HPAI
H5N1 patients may present with a wide range of clinical signs and
symptoms, often progressing to respiratory failure and requiring
invasive mechanical ventilation support [9,10]. Human infections
with HPAI H5N1 virus are associated with high mortality, but it is
still largely unknown which demographic and clinical factors place
an individual at higher risk of death. Studies from Hong Kong
(SAR, China) [11] and Indonesia [12] have found associations
between longer delays to hospitalization and increased HPAI
H5N1 disease severity and mortality, but comprehensive world-
wide analyses are not available. Therapeutic options include
supportive care and antivirals [13]; antivirals are most effective in
decreasing respiratory failure and mortality if treatment is started
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early [14,15]. However, limited prognostic information is available
to guide the use of scarce resources.
We aimed to statistically model individuals at highest risk of
mortality from HPAI H5N1 virus infection. We systemically
searched for all available data on human infections with HPAI
H5N1 viruses to create a database of cases reported since the
initial 1997 outbreak in Hong Kong (SAR, China). To model
demographic and clinical predictors of mortality in human
infection, we developed a decision tree using Classification and
Regression Tree (CART) methodology [16]. These findings may
help guide public health officials and policymakers in distributing
limited resources.
Methods
Search Strategy and Inclusion Criteria
We used World Health Organization (WHO) Global Alert and
Response (GAR) updates and performed systematic searches of
three databases (PubMed, Scopus, and Google Scholar) to compile
all confirmed and possible human cases of HPAI H5N1 virus
infection. We included all articles published between January 1,
1997 and April 19, 2013 with keywords ‘‘H5N1,’’ ‘‘human,’’ and
‘‘humans.’’ We excluded articles that described non-human cases
(animal or molecular studies), did not report individual case data,
did not include data on laboratory-confirmed HPAI H5N1 cases,
or described asymptomatic infections (e.g., seroprevalence studies).
We defined confirmed human H5N1 cases using the World
Health Organization guidelines, requiring isolation of HPAI
H5N1 virus, a positive result by reverse transcription polymerase
chain reaction (RT-PCR) testing of clinical specimens using H5-
specific primers and probes, an elevated H5-specific antibody titer
of $1:80 (or equivalent using the WHO protocol), or at least a
fourfold rise in H5N1 virus neutralization antibody titer in paired
sera [17]. We defined possible cases as those lacking laboratory
confirmation but having symptoms and known contact with a
confirmed human HPAI H5N1 case. This definition is more
restrictive than the WHO definition of suspected and probable
cases. The WHO definitions involve information on exposures,
such as to raw poultry meat or environments contaminated with
wild bird feces, that was not available to us in the literature. We
then created Abstraction Form S1 based on clinical and
demographic variables known to be relevant to influenza A
(H1N1)pdm09 and useful in clinical practice.
We initially created a database of all cases published on the
WHO Global Alert and Response (GAR) website, which includes
only HPAI H5N1 cases reported from November 2003 to present.
Although clinical laboratory data were not provided for each case,
these were assumed to satisfy WHO reporting criteria. We then
attempted to match all cases identified through literature sources
to this database.
Data Extraction
Two independent investigators (RP, MM) evaluated each article
for inclusion; a third investigator (NK) resolved all disagreements.
We included articles in all languages. A professional translator
(YX) evaluated the numerous Chinese language articles. For
Japanese, Russian, French, and Spanish languages, we verified
inclusion with native-language speakers. For all other languages,
we used PDF OCR X Community Edition for file conversion into
text format (version 1.9.32, Burnaby, British Columbia) and a
web-based translator for translation into English [18].
We then extracted the predefined set of variables for each case
(Abstraction Form S1), systematically comparing demographic
variables to avoid duplication. One co-author (TU) reviewed
discrepancies between the WHO GAR publications and the
published medical literature; based on his familiarity with several
of these cases, we resolved discrepancies using data from the
literature.
Variables
Using our pre-defined Abstraction Form S1, we extracted our
primary outcome variable (mortality), demographic predictor
variables (age, sex, country, per capita government expenditure
on health [PCGEH], season, body mass index [BMI], and
comorbidities), infection-related predictor variables (contact with
poultry, delay from symptom onset to hospitalization, and whether
the case was part of a cluster of known cases), and hospitalization
predictor variables (laboratory data, pneumonia, acute respiratory
distress syndrome [ARDS], and mechanical ventilation). We
defined a case cluster as at least two geographically and temporally
proximal (epidemiologically-linked) confirmed human HPAI
H5N1 cases.
We obtained PCGEH at the average exchange rate (USD) for
each country and year through the World Health Organization
Global Health Observatory Data Repository [19]. Since data
beyond 2011 are unavailable, data from 2011 were carried
forward for later cases. Finally, we created a season variable based
on month (Summer: June–August; Fall: September–November;
Winter: December–February; Spring: March–May).
Statistical Analysis
We performed all statistical analyses using R software (Version
3.0.0, Vienna, Austria) and defined statistical significance by an
alpha level of 0.05. Our primary analytic goal was to develop a
parsimonious decision tree model with optimal predictive ability
for mortality following HPAI H5N1 virus infection. We first
assessed bivariate associations between each predictor variable and
mortality using logistic regression models. For continuous predic-
tors (age, delay from hospitalization to symptom onset, and
PCGEH), we visually assessed for the linearity assumption (Figure
S1).
All continuous predictor variables had potentially nonlinear
relationships with death, so we analyzed them both in continuous
and in categorical form. We divided age into four categories
similar to those associated with mortality from influenza A
(H1N1)pdm09: 0–4 years, .4–18 years, .18–25 years, and
.25 years [20]. PCGEH was split in quartiles. We created three
groups of countries because most countries had very few cases;
including these countries as individual predictors would cause
over-fitting and statistical instability [21]. We therefore defined
three categories of countries: Indonesia (n = 171), Egypt (n = 169),
and all others combined (‘‘Other’’). Fewer than 100 cases were
documented in each of the countries in the ‘‘Other’’ category.
As we performed initial analyses, we found that several
parameters were missing data. We therefore developed a decision
tree using CART methods [16]. CART models generally yield
comparable results to logistic regression models, but unlike logistic
regression, CART methods do not require missing data to be
deleted or imputed (minimizing possible bias), capture higher-
order interactions more easily, do not assume an underlying linear
model, and generate a graphical prediction tool that is easy for
practitioners to use and interpret [22,23].
CART procedures build a decision tree by selecting locally
optimal splits that minimize ‘‘impurity’’ on the outcome measure
of the two child nodes. Low impurity on the outcome measure
indicates that the classifier performs well at separating observations
with one outcome (e.g., death) from observations with another
outcome (e.g., survival). For example, if sex is a strong risk factor
Predictors of Mortality from H5N1 Virus Infection
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for mortality, then mortality will be similar within each sex and
different between sexes. All possible binary splits are considered for
both continuous and categorical variables. The initial split is
chosen as the single best classifier on the outcome measure; then,
within each child node, the splitting procedure is recursively
repeated until no further splits are possible. All observations,
including those with missing data, are included in model-building:
at each split, the impurity index is simply calculated over only
those observations not missing the relevant predictor variable. To
avoid over-fitting, the initial large tree is pruned based on a cost-
complexity index, which captures the tradeoff between better fit
and added complexity due to each additional node in the tree [21].
The optimal final tree, defined as the tree with the lowest expected
misclassification, is selected using cross-validation [16].
We assessed model performance using a receiver operating
characteristic (ROC) curve and corresponding area under the
curve (AUC) [23]. We constructed bootstrapped confidence
intervals for the sensitivity and specificity thresholds of the ROC
curve and for the AUC. To replicate the results of the CART
model, we developed corresponding prognostic models using
complete-case logistic regression (Table S1) and multiply-imputed
logistic regression (Table S2).
Results
Report Identification and Eligibility
Our search identified 3,227 potentially relevant articles
published since 1997 (Figure 1). After removing 1,540 duplicate
articles and 7 unavailable articles, two investigators (RP, MM)
independently reviewed the remaining 1,680 articles. The review
process yielded 163 articles meeting inclusion criteria, comprising
617 unique cases. Nearly all studies meeting inclusion criteria were
case reports, so we did not assess methodological quality criteria.
Data Quality
The quality of data reporting on HPAI H5N1 cases was
inconsistent. Several variables had missing data, most with
homogeneity among the non-missing values; these were not
included in the analysis (Figure 2). In other words, BMI, presence
of comorbidities, whether the case was part of a cluster, laboratory
data, presence of pneumonia, ARDS, and use of mechanical
ventilation were mentioned almost exclusively for cases in which
the parameter was present rather than absent. For example, only
10 case reports noted that a case had not received mechanical
ventilation, 63 noted that a case had received ventilation, and the
remaining 544 offered no information. In light of this limitation of
the case-reporting process, we narrowed the scope of our
prognostic model to include only demographic and infection
variables, as post-admission hospital variables were usually
unavailable. We removed these variables from analysis because
we would have limited statistical power to assess their effects, and
infrequently recorded homogenous variables may have little
clinical utility (see Figure 2 for details on excluded variables).
The eight variables used in analysis had 9% missing observations.
Participant Characteristics
Demographic and clinical characteristics of the 617 cases are
presented in Table 1. Overall mortality was 59%. Cases occurred
in 15 countries, with 55% reported from Indonesia and Egypt
combined (n = 171 and n = 169, respectively). 140 cases occurred
within epidemiologically- and geographically-linked clusters, 13
occurred sporadically, and cluster status was unknown for the
remaining 464. Cases tended to be young adults (median age 18
years; IQR 6–29). There was a marginal predominance of females
(54% female, chi-square = 3.75, df = 1, p = 0.05). For all demo-
graphic parameters reported in the WHO GAR case summary
(year, country, and mortality) [8], distributions for our literature-
based dataset and the WHO summary were nearly identical
(Table 1). We find little indication, therefore, of reporting or
selection bias in our sample.
Bivariate Associations with Mortality
In bivariate logistic regression models, risk factors for mortality
were longer delay to hospitalization, infection not in Egypt, older
age, lower PCGEH, likely contact with poultry, female sex, and
illness onset during summer months (Table 2).
Decision Tree Model for Mortality
The decision tree, trained on all 607 cases with observed
mortality, evaluated seven candidate predictor variables: age,
PCGEH, country group, delay from symptom onset to hospital-
ization, sex, contact with poultry, and season. The variables are
listed here in descending order of variable importance in the
decision tree, a measure based on split quality. The first four were
used as splitting variables in the final, pruned tree (Figure 3).
The first node splits on age, with higher mortality in patients at
least 4.5 years of age. In the second level of the tree, young
children (,4.5 years) in high-PCGEH settings ($32.65 USD) are
predicted to survive, with the lowest mortality (4%) of all groups.
Young children in low-PCGEH settings (,32.65 USD) are
predicted to die (57% mortality).
Older patients ($4.5 years) are further partitioned by country.
Older cases in Indonesia are predicted to die, with the highest
mortality (84%) of all groups. Older cases not in Indonesia are
classified by one final split based on delay to hospitalization: cases
with a short delay to hospitalization (,2.5 days) are predicted to
survive (33% mortality), while cases hospitalized later after illness
onset ($2.5 days) are predicted to die (65% mortality).
Model Performance
We assessed the decision tree’s performance with an ROC curve
and corresponding AUC (Figure 4). Tested on all cases without
missing data on mortality or any of the seven candidate model
variables (n = 301), the AUC was 0.81 (95% CI: 0.76–0.86),
indicating very good discrimination. Performance remained strong
(AUC = 0.75; 95% CI: 0.71–0.78) when the model was instead
tested on all cases with observed outcome but potentially missing
any subset of the predictors (n = 607). The latter is a more difficult
prediction task, requiring surrogate splitting based on the missing
predictors. In surrogate splitting, the value of the missing predictor
is estimated using the other predictors. This estimated value is then
used as usual to classify the observation.
Sensitivity Analysis
We also performed complete-case logistic regression and
multiply-imputed logistic regression including all predictor vari-
ables that were candidates for inclusion in the CART model. All
models yielded similar results (Tables S1 and S2).
Discussion
We investigated factors associated with increased mortality
following HPAI H5N1 virus infection to guide public health
messages, resource distribution, and triage of infected individuals.
We conducted a systematic search of all available literature
describing human cases of HPAI H5N1 virus infection and
developed a prognostic decision tree. We find that age, health
expenditure, delay from symptom onset to hospitalization, and
Predictors of Mortality from H5N1 Virus Infection
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country are significant predictors of mortality. Additionally, we
find that data reporting is incomplete and poorly standardized.
Our finding that HPAI H5N1 mortality is lowest in young
children aged 0 to 4.5 years is different from established patterns
observed for seasonal influenza in which mortality is high in
infants and young children [24,25]. Cultural influences may
contribute to lower mortality from HPAI H5N1 in young children:
in Egypt, for example, parents tend to seek medical care for ill
children promptly, and pediatric cases tend to receive earlier
hospitalization and treatment with oseltamivir [26]. For seasonal
influenza, elderly persons are at the highest risk of mortality of all
age groups [27]. However, we could not determine if HPAI H5N1
in humans parallels this pattern because the literature contained
only four case reports in individuals aged 65 years or older. The
rarity of HPAI H5N1 cases among elderly may reflect less frequent
exposure to poultry or other, unknown factors.
Not surprisingly, we found that reduced national healthcare
expenditure is associated with higher mortality from HPAI H5N1.
This relationship is common with many diseases at a country-
specific level. We were unable to delineate the complete
Figure 1. Literature search strategy. *: Total number of excluded articles is less than the sum of articles excluded by each criterion because most
articles failed multiple criteria.
doi:10.1371/journal.pone.0091630.g001
Predictors of Mortality from H5N1 Virus Infection
PLOS ONE | www.plosone.org 4 March 2014 | Volume 9 | Issue 3 | e91630
mechanisms responsible for this finding, but healthcare quality
may be a mediator. Maternal mortality, generally considered a
sensitive indicator of overall quality and accessibility of healthcare,
is widely discrepant across affected countries in our study. For
example, maternal mortality per 100,000 live births is 55 in China,
95 in Vietnam, and 440 in Cambodia [28].
We also find that a longer delay from HPAI H5N1 illness onset
to hospitalization is associated with higher mortality, a finding
previously reported in smaller, geographically restricted datasets
[11,12,26,29]. The reason for this is unclear but may be related to
delayed administration of antiviral treatment, associated in
observational analyses with higher mortality [12,14,15]. Ferrets
experimentally inoculated with HPAI H5N1 viruses and treated
early with oseltamivir had significantly reduced clinical symptoms
and mortality [30,31]. We did not have access to detailed data on
antiviral treatment; however, our results support public health
messages in countries with endemic HPAI H5N1 or periodic
poultry outbreaks recommending prompt antiviral treatment and
H5N1 testing for symptomatic persons with a recent history of
poultry contact.
Consistent with WHO cumulative case counts and previously
published analyses [32], we found that Indonesian cases have very
high mortality (82%). This may be secondary to a combination of
unknown factors, as well as several of the other risk factors we
Figure 2. Variable summary and patterns of missing data. *: Variable was excluded from modeling. Each row represents one of 617 human
cases; each column represents a variable abstracted from the literature. The color of each cell indicates whether the corresponding variable was
missing (dark green) or observed (light green) for the given case.
doi:10.1371/journal.pone.0091630.g002
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Table 1. Demographic and clinical characteristics of study sample.
Characteristic Literature search (n = 617)
Reported WHO HPAI H5N1 cases as of Oct 31,
2013 [8,48–50] (n = 644)
Year
1997 24 (4%) not reported
1998 4 (0.6%) not reported
2003 7 (1%) 4 (0.6%)
2004 53 (9%) 46 (7%)
2005 75 (12%) 98 (15%)
2006 116 (19%) 115 (18%)
2007 90 (15%) 88 (14%)
2008 45 (7%) 44 (7%)
2009 53 (9%) 73 (11%)
2010 48 (8%) 48 (7%)
2011 62 (10%) 62 (10%)
2012 29 (5%) 32 (5%)
2013 10 (2%) 34 (5%)
Missing 1 (0.1%)
Country
Indonesia 171 (28%) 194 (30%)
Egypt 169 (27%) 173 (27%)
Vietnam 96 (16%) 125 (19%)
China 50 (8%) 45 (7%)
Cambodia 36 (6%) 44 (7%)
Hong Kong (SAR, China) 29 (5%) not reported
Thailand 27 (4%) 25 (4%)
Turkey 11 (2%) 12 (2%)
Azerbaijan 9 (1%) 8 (1%)
Bangladesh 6 (1%) 7 (1%)
Pakistan 5 (0.8%) 3 (0.5%)
Iraq 3 (0.5%) 3 (0.5%)
Laos 2 (0 3%) 2 (0.3%)
Djibouti 1 (0.2%) 1 (0.2%)
Myanmar 1 (0.2%) 1 (0.2%)
Nigeria 1 (0.2%) 1 (0.2%)
PCGEH (USD) 24.8 (13.7–49.0) not reported
Sex
Female 331 (54%) not reported
Male 283 (46%)
Missing 3 (0.5%)
Age (yrs) 18 (6–29) not reported
Missing 9 (1%)
Season





Delay to hospitalization from symptom onset (days) 4 (2–6) not reported
Missing 242 (39%)
Contact with poultry
Yes 356 (58%) not reported
Predictors of Mortality from H5N1 Virus Infection
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identified occurring more frequently in Indonesian cases. Such
confounding cannot be adequately resolved with either CART or
standard multiple regression procedures [33]. As noted above,
Indonesia has limited healthcare resources (demonstrated by 380
maternal deaths per 100,000 live births in Indonesia compared to
55 and 170, respectively, in China and Egypt [28]). Additionally,
physician density per 1,000 population is much lower in Indonesia
(0.13) than in Egypt (0.54) and China (1.64), the other two
countries with the highest number of HPAI H5N1 cases [28].
HPAI H5N1 cases may be recognized late in the clinical course
and therefore treated with antivirals relatively late; previous
analyses of Indonesian cases found a median time from symptom
Table 1. Cont.
Characteristic Literature search (n = 617)
Reported WHO HPAI H5N1 cases as of Oct 31,
2013 [8,48–50] (n = 644)




Death 362 (59%) 382 (59%)
Survival 245 (40%) 262 (41%)
Missing 10 (2%)
Data are frequency (%) or median (first quartile – third quartile).
Percentages are calculated including missing observations.
PCGEH = per capita government expenditure on health.
doi:10.1371/journal.pone.0091630.t001
Table 2. Bivariate associations of candidate predictor variables with mortality.
Variable
Survived




coefficient p value model c-statistic
Delay to hospitalization 3 (1–5) 5 (3–6) 1.31 (1.20, 1.45) ,0.0001 ,0.0001 0.70
Country Egypt 108 (64%) 61 (36%) Ref Ref
Indonesia 30 (18%) 141 (82%) 8.32 [5.08, 13.95] ,0.0001 ,0.0001 0.69
Other 107 (40%) 160 (60%) 2.65 [1.78, 3.96] ,0.0001
Age group 0–4 89 (74%) 32 (26%) 0.14 [0.07, 0.25] ,0.0001
.4–18 64 (33%) 128 (67%) 0.75 [0.42, 1.32] 0.33 ,0.0001 0.65
.18–25 23 (27%) 61 (73%) Ref Ref
.25 66 (33%) 136 (67%) 0.78 [0.44, 1.35] 0.38
Age 9.5 (3–27) 20 (12–30) 1.03 [1.02, 1.04] ,0.0001 ,0.0001 0.64
PCGEH group ,13.7 62 (41%) 89 (59%) Ref Ref
.13.7–24.8 31 (20%) 122 (80%) 2.74 [1.66, 4.61] 0.0001 ,0.0001 0.63
.24.8–49.0 84 (52%) 77 (48%) 0.64 [0.41, 0.998] 0.05
.49.0 68 (48%) 74 (52%) 0.76 [0.48, 1.20] 0.24
Contact with poultry No 10 (53%) 9 (47%) Ref Ref
Yes 174 (49%) 182 (51%) 1.16 [0.46, 2.99] 0.75 ,0.0001 0.59
Likely yes 8 (13%) 54 (87%) 7.50 [2.38, 25.15] 0.0007
PCGEH 35.1 (13.7–49.1) 23.2 (16.4–38.0) 0.994 [0.989, 0.998] 0.007 0.004 0.59
Sex Male 134 (55%) 147 (45%) Ref 0.0007 0.0007 0.57
Female 110 (41%) 213 (59%) 1.77 [1.27, 2.45]
Season Summer 17 (27%) 47 (73%) Ref Ref
Fall 37 (44%) 48 (56%) 0.47 [0.23, 0.94] 0.03 0.02 0.57
Winter 106 (38%) 174 (62%) 0.59 [0.32, 1.07] 0.09
Spring 84 (47%) 93 (53%) 0.40 [0.21, 0.74] 0.004
Data are presented as medians (IQR) or frequencies (%). Variables are ordered roughly by statistical significance. Row percentages are calculated excluding missing data.
P-values were calculated using Wald’s z-test for logistic regression coefficients and the likelihood-ratio test for regression models.
PCGEH = per capita government expenditure on health.
doi:10.1371/journal.pone.0091630.t002
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onset to treatment with oseltamivir of 7 days [12,32]. Our findings
again support prioritizing public health messages urging early
medical attention in case of influenza signs and symptoms,
especially for individuals in Indonesia.
We were surprised to find inconsistent case reporting in the
literature. While the WHO maintains summary data on worldwide
cases of HPAI H5N1, this aggregation provides minimal
individual-level demographic and clinical characteristics [8]. The
detailed WHO Clinical Case Summary Form for reporting human
HPAI H5N1 cases [34] is rarely used in practice [35].
Additionally, reporting and surveillance practices can differ greatly
by country and locality [35,36]. Relevant clinical factors such as
the presence of co-morbidities and use of mechanical ventilation
are mentioned almost exclusively for cases in which the parameter
was present rather than absent, and important demographic
factors, such as place of residence (urban vs. rural), are rarely
noted [37].
Reporting bias may exist; practitioners may consider a diagnosis
of HPAI H5N1 only for more severe cases, limiting reports of
subclinical or asymptomatic infections in the medical literature.
Controversy exists over the extent to which such a bias may inflate
HPAI H5N1 mortality estimates. A meta-analysis reported an
average seroprevalence of HPAI H5N1 virus antibodies of 1 to
2%, potentially translating into a substantial number of unreport-
ed cases worldwide [38]; however, others have criticized these
Figure 3. Classification tree for mortality following highly pathogenic avian influenza H5N1 virus infection. Model was trained on all
n = 607 cases with observed mortality. The following variables were candidates for inclusion: age, PCGEH, country, delay to hospitalization, sex,
season, contact with poultry.
doi:10.1371/journal.pone.0091630.g003
Figure 4. ROC curve for pruned CART tree. ROC curve represents
performance of CART model on all cases without missing observations
on any model variables (n = 301). Error bars represent bootstrapped
95% confidence intervals for sensitivity-specificity thresholds.
doi:10.1371/journal.pone.0091630.g004
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findings for the use of non-representative, high-risk populations
[39]. One review included 29 serologic studies and found no clear
serological evidence of ‘‘mild’’ HPAI H5N1 virus infections [40].
However, some studies have reported serologic evidence of rare,
sporadic asymptomatic or clinically mild HPAI H5N1 virus
infection [41–43]. Although more research is required, large
numbers of mild, unreported HPAI H5N1 cases appear unlikely.
Potential methodological limitations include variability in
surveillance and clinical care, lack of data on antiviral treatment,
and time from illness onset to start of antiviral treatment.
Additionally, time from onset to hospitalization may not equal
time to oseltamivir treatment onset. We noted a high proportion of
unreported variables. Complete-case analysis can cause bias and
imprecision in regression coefficient estimates, particularly if data
are not missing at random. Nevertheless, we performed three
analytic techniques with fundamentally different approaches to
handling missing data, and they all yielded similar results. Like all
classification trees, our model demonstrates some statistical
instability [21]. This arises due to the hierarchical nature of node
splitting, whereby small changes in the training data can change
the splits and resulting tree. Since statistical methods to improve
stability, such as bagging, generally have the disadvantage of
obscuring the classification procedure from interpretation [21], we
opted to optimize interpretability and stability with a conserva-
tively pruned decision tree. Additionally, we were unable to assess
the role of host genetic factors, which have been postulated to
increase the risk of severe influenza disease [44–47].
From a policy standpoint, improved recognition of disease
(albeit rare) and early delivery of healthcare, especially antiviral
treatment, could result in reduced hospitalization costs, decreased
morbidity, and lower mortality from HPAI H5N1 virus infection.
To facilitate analyses, the idiosyncratic case reporting process our
study detected could be greatly improved by widespread adoption
of a standardized data collection form, such as an online database.
Currently, the WHO receives case report data from officials at
Ministries of Health, which collect case report data from local
hospitals. A convenient and efficient mode of data collection may
enable improved communication at both reporting junctures.
We have established a predictive classification tree model to
estimate human HPAI H5N1 mortality based on readily available
clinical and demographic predictors: age, delay from symptom
onset to hospitalization, country, and PCGEH. Our resulting
publicly accessible online algorithm (http://flubusters.stanford.
edu) may allow public health officials and clinicians to triage
patients and distribute limited resources. To our knowledge, our
work is the most complete literature search and analysis of
worldwide human cases of HPAI H5N1. Contingent on improved
data collection, future research should investigate the predictive
ability of clinical and demographic characteristics not currently
available in the case literature. Improved reporting and predictive
strategies are essential, particularly in light of recent research [45–
47] that suggests only a few virus mutations may increase the risk




Figure S1 Probability of death conditional on continu-
ous predictors. Error bars (6 SE) are based on the binomial
distribution.
(EPS)
Table S1 Complete-cases logistic regression.
(PDF)




We thank Charlotte Chae for her invaluable assistance in creating
graphics. We are also grateful to the many authors whose open-source R
packages were indispensable: John Fox and Sanford Weisberg (package
‘‘car’’); James Honaker, Gary King, and Matthew Blackwell (package
‘‘Amelia’’); Frank Harrell Jr. (packages ‘‘Hmisc’’ and ‘‘rms’’); Terry
Therneau, Beth Atkinson, and Brian Ripley (package ‘‘rpart’’); Xavier
Robin, Natacha Turck, Alexandre Hainard, Natalia Tiberti, Frédérique
Lisacek, Jean-Charles Sanchez, and Markus Müller (package ‘‘pROC’’);
Stef van Buuren and Karin Groothuis-Oudshoorn (package ‘‘mice’’); and
Gregory R. Warnes (package ‘‘gplots’’).
Author Contributions
Conceived and designed the experiments: NK. Performed the experiments:
MM RP. Analyzed the data: MM. Wrote the manuscript: PR MM.
Compiled and organized data: RP. Served as reviewers for the systematic
search: RP MM. Provided critical edits to analysis and interpretation of
data: MG. Advised on article inclusion, background, analysis and
interpretation of data, and contributed to revising the manuscript: TMU.
Provided advice on design of work: JB. Provided professional translation
for acquisition of Chinese data: YX. Conceptualized the project, defined
research questions, collaborated on substantial portions of manuscript
writing, and served as an arbitrator for the systemic search: NK.
References
1. Chan PK (2002) Outbreak of avian influenza A(H5N1) virus infection in Hong
Kong in 1997. Clin Infect Dis 34 Suppl 2: S58–S64.
2. Chmielewski R, Swayne DE (2011) Avian influenza: public health and food
safety concerns. Annu Rev Food Sci Technol 2: 37–57.
3. Coker R, Mounier-Jack S (2006) Pandemic influenza preparedness in the Asia-
Pacific region. Lancet 368: 886–889.
4. Coker RJ, Hunter BM, Rudge JW, Liverani M, Hanvoravongchai P (2011)
Emerging infectious diseases in southeast Asia: regional challenges to control.
Lancet 377: 599–609.
5. Cunha BA (2004) Influenza: historical aspects of epidemics and pandemics.
Infect Dis Clin North Am 18: 141–155.
6. Yalcin C, Sipahi C, Aral Y, Cevger Y (2010) Economic effect of the highly
pathogenic avian influenza H5N1 outbreaks among turkey producers, 2005–06,
Turkey. Avian Dis 54: 390–393.
7. Pongcharoensuk P, Adisasmito W, Sat le M, Silkavute P, Muchlisoh L, et al.
(2012) Avian and pandemic human influenza policy in South-East Asia: the
interface between economic and public health imperatives. Health Policy Plan
27: 374–383.
8. World Health Organization (2013) Cumulative number of confirmed
human cases for avian influenza A(H5N1) reported to WHO, 2003–201.
Available: http://www.who.int/influenza/human_animal_interface/EN_GIP_
20130426CumulativeNumberH5N1cases.pdf. Accessed 18 Jul 2013.
9. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et
al. (2008) Update on avian influenza A (H5N1) virus infection in humans.
N Engl J Med 358: 261–273.
10. Uyeki TM (2009) Human infection with highly pathogenic avian influenza A
(H5N1) virus: review of clinical issues. Clin Infect Dis 49: 279–290.
11. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, et al. (1998) Clinical
features and rapid viral diagnosis of human disease associated with avian
influenza A H5N1 virus. Lancet 351: 467–471.
12. Kandun IN, Tresnaningsih E, Purba WH, Lee V, Samaan G, et al. (2008)
Factors associated with case fatality of human H5N1 virus infections in
Indonesia: a case series. Lancet 372: 744–749.
13. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, et al. (2009) Clinical
features of human influenza A (H5N1) infection in Vietnam: 2004–2006. Clin
Infect Dis 48: 1639–1646.
14. Adisasmito W, Chan PK, Lee N, Oner AF, Gasimov V, et al. (2010)
Effectiveness of antiviral treatment in human influenza A(H5N1) infections:
analysis of a Global Patient Registry. J Infect Dis 202: 1154–1160.
Predictors of Mortality from H5N1 Virus Infection
PLOS ONE | www.plosone.org 9 March 2014 | Volume 9 | Issue 3 | e91630
15. Chan PK, Lee N, Zaman M, Adisasmito W, Coker R, et al. (2012) Determinants
of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis 206:
1359–1366.
16. Breiman L, Friedman J, Stone CJ, Olshen RA (1984) Classification and
regression trees. Chapman and Hall/CRC. 368 p.
17. World Health Organization (2013) WHO case definitions for human infections
with influenza A(H5N1) virus. Available: http://www.who.int/influenza/
resources/documents/case_definition2006_08_29/en/index.html. Accessed 18
July 2013.
18. Google Translate. Available: http://translate.google.com/. Accessed 18 July
2013.
19. World Health Organization (2013) Global Health Observatory Data Repository.
Available: http://apps.who.int/gho/data/view.main. Accessed 18 July 2013.
20. Cox CM, Blanton L, Dhara R, Brammer L, Finelli L (2011) 2009 pandemic
influenza A (H1N1) deaths among children – United States, 2009–2010. Clin
Infect Dis 52 Suppl 1: S69–S74.
21. Hastie T, Tibshirani R, Friedman J (2011) The elements of statistical learning:
data mining, inference, and prediction. Springer. 745 p.
22. Muller R, Mockel M (2008) Logistic regression and CART in the analysis of
multimarker studies. Clin Chim Acta 394: 1–6.
23. Harrell FE (2001) Regression modeling strategies: with applications to linear
models, logistic regression, and survival analysis. Springer. 571 p.
24. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, et al. (2010) Global
burden of acute lower respiratory infections due to respiratory syncytial virus in
young children: a systematic review and meta-analysis. Lancet 375: 1545–1555.
25. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, et al. (2005)
Influenza-associated deaths among children in the United States, 2003–2004.
N Engl J Med 353: 2559–2567.
26. Kandeel A, Manoncourt S, Abd el Kareem E, Mohamed Ahmed AN, El-Refaie
S, et al. (2010) Zoonotic transmission of avian influenza virus (H5N1), Egypt,
2006–2009. Emerg Infect Dis 16: 1101–1107.
27. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003)
Mortality associated with influenza and respiratory syncytial virus in the United
States. JAMA 289: 179–186.
28. NationMaster. Available: http://www.nationmaster.com/index.php. Accessed
19 July 2013.
29. Kayali G, Webby RJ, Ducatez MF, El Shesheny RA, Kandeil AM, et al. (2011)
The epidemiological and molecular aspects of influenza H5N1 viruses at the
human-animal interface in Egypt. PLoS One 6: e17730.
30. Govorkova EA, Ilyushina NA, Boltz DA, Douglas A, Yilmaz N, et al. (2007)
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of
H5N1 influenza virus. Antimicrob Agents Chemother 51: 1414–1424.
31. Boltz DA, Rehg JE, McClaren J, Webster RG, Govorkova EA (2008)
Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and
mortality in a ferret model. J Infect Dis 197: 1315–1323.
32. Adisasmito W, Aisyah DN, Aditama TY, Kusriastuti R, Trihono, et al. (2013)
Human influenza A H5N1 in Indonesia: health care service-associated delays in
treatment initiation. BMC Public Health 13: 571.
33. Miller GA, Chapman JP (2001) Misunderstanding analysis of covariance.
J Abnorm Psychol 110: 40–48.
34. World Health Organization (2013) WHO H5N1 clinical case summary
form. Available: http://www.who.int/influenza/resources/documents/
SummaryForm07.pdf. Accessed 19 Jul 2013.
35. Bird SM, Farrar J (2008) Minimum dataset needed for confirmed human H5N1
cases. Lancet 372: 696–697.
36. Murakami DR, Ishida DR, Tanaka DR (2008) Multi-country comparative
assessment of the surveillance of avian influenza (H5N1) human cases in Asian
countries. 13th International Congress on Infectious Diseases.
37. Cowling BJ, Jin L, Lau EH, Liao Q, Wu P, et al. (2013) Comparative
epidemiology of human infections with avian influenza A H7N9 and H5N1
viruses in China: a population-based study of laboratory-confirmed cases. Lancet
382: 129–137.
38. Wang TT, Parides MK, Palese P (2012) Seroevidence for H5N1 influenza
infections in humans: meta-analysis. Science 335: 1463.
39. Van Kerkhove MD, Riley S, Lipsitch M, Guan Y, Monto AS, et al. (2012)
Comment on ‘‘Seroevidence for H5N1 influenza infections in humans: meta-
analysis’’. Science 336: 1506; author reply 1506.
40. Toner ES, Adalja AA, Nuzzo JB, Inglesby TV, Henderson DA, et al. (2013)
Assessment of serosurveys for H5N1. Clin Infect Dis 56: 1206–1212.
41. Liao Q, Bai T, Zhou L, Vong S, Guo J, et al. (2013) Seroprevalence of
antibodies to highly pathogenic avian influenza A (H5N1) virus among close
contacts exposed to H5N1 cases, China, 2005–2008. PLoS One 8: e71765.
42. Cavailler P, Chu S, Ly S, Garcia JM, Ha DQ, et al. (2010) Seroprevalence of
anti-H5 antibody in rural Cambodia, 2007. J Clin Virol 48: 123–126.
43. Vong S, Ly S, Van Kerkhove MD, Achenbach J, Holl D, et al. (2009) Risk
factors associated with subclinical human infection with avian influenza A
(H5N1) virus – Cambodia, 2006. J Infect Dis 199: 1744–1752.
44. Horby P, Nguyen NY, Dunstan SJ, Baillie JK (2012) The role of host genetics in
susceptibility to influenza: a systematic review. PLoS One 7: e33180.
45. Horby P, Sudoyo H, Viprakasit V, Fox A, Thai PQ, et al. (2010) What is the
evidence of a role for host genetics in susceptibility to influenza A/H5N1?
Epidemiol Infect 138: 1550–1558.
46. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts
the morbidity and mortality associated with influenza. Nature 484: 519–523.
47. Horby P, Nguyen NY, Dunstan SJ, Baillie JK (2013) An updated systematic
review of the role of host genetics in susceptibility to influenza. Influenza Other
Respir Viruses 7 Suppl 2: 37–41.
48. Western Pacific Regional Office of the World Health Organization (2013) 22nd
new human case of avian influenza H5N1 in Cambodia in 2013. Available:
http://www.wpro.who.int/mediacentre/releases/2013/20131104/en/index.
html. Accessed 12 Jul 2013.
49. Western Pacific Regional Office of the World Health Organization (2013) 23rd
new human case of avian influenza H5N1 in Cambodia in 2013. Available:
http://www.wpro.who.int/mediacentre/releases/2013/20131105/en/index.
html. Accessed 12 Jul 2013.
50. Western Pacific Regional Office of the World Health Organization (2013) Avian
influenza A (H5N1) weekly update number 406. Available: http://www.wpro.
who.int/emerging_diseases/AI.weekly.31Oct2013.pdf. Accessed 12 Jul 2013.
Predictors of Mortality from H5N1 Virus Infection
PLOS ONE | www.plosone.org 10 March 2014 | Volume 9 | Issue 3 | e91630
